Unichem Laboratories Ltd.

View in App
372.00 -0.10 ▼0.0%

06 June 2023, 04:01:00 PM
Volume: 3,980

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.unichemlabs.com
Market Cap 2,617.33 Cr.
Enterprise Value(EV) 2,731.12 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -28.72 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 33.76 Trailing Twelve Months Ending 2023-03
Book Value / Share 345.90 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.08 Calculated using Price: 372.00
Dividend Yield 1.08 Period Ending 2022-03
No. of Shares Subscribed 7.04 Cr. 70,405,751 Shares
FaceValue 2
About Unichem Laboratories Ltd.
Unichem Laboratories, incorporated in 1962, is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs). The company was promoted by the late Amrut Mody, a pioneer in the Indian pharmaceuticals business.

Unichem Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Unichem Laboratories Ltd. Performance

View details >>
1 Day
-0.03%
1 Week
-0.23%
1 Month
-1.34%
3 Month
+22.79%
6 Month
+9.38%
1 Year
+51.59%
2 Year
+14.34%
5 Year
+59.83%
10 Year
+121.36%

Unichem Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 16.62 8.95 11.92 10.77 136.04 -0.90 -2.37 1.37 1.32
Return on Capital Employed (%) 21.84 9.29 14.97 13.42 162.77 -1.77 -1.49 2.12 1.04
Return on Assets (%) 11.56 6.55 8.82 7.68 108.06 -0.75 -1.94 1.11 1.06

Unichem Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 817 868 954 1,064 2,680 2,620 2,531 2,557 2,618 2,435
Non Curr. Liab. 98 74 76 64 46 10 44 49 144 108
Curr. Liab. 230 212 275 393 464 503 567 506 552 640
Minority Int.
Equity & Liab. 1,145 1,153 1,305 1,521 3,190 3,133 3,142 3,112 3,314 3,183
Non Curr. Assets 564 589 673 772 854 1,094 1,455 1,734 1,666 1,591
Curr. Assets 581 564 632 748 2,336 2,039 1,686 1,377 1,648 1,592
Misc. Exp. not W/O
Total Assets 1,145 1,153 1,305 1,521 3,190 3,133 3,142 3,112 3,314 3,183

Unichem Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 1,133 1,202 1,333 1,540 1,380 1,188 1,104 1,235 1,270 1,343
Other Income 42 21 19 6 3,278 98 91 50 48 39
Total Income 1,176 1,223 1,352 1,546 4,658 1,287 1,195 1,285 1,317 1,382
Total Expenditure -956 -1,101 -1,169 -1,358 -1,358 -1,269 -1,155 -1,144 -1,197 -1,389
PBIDT 220 122 183 188 3,300 17 40 141 120 -7
Interest -3 -3 -3 -3 -8 -8 -8 -5 -6 -17
Depreciation -46 -41 -39 -44 -51 -67 -82 -84 -91 -113
Taxation -43 -2 -29 -33 -696 34 -12 -17 11 -26
Exceptional Items -4 -39
PAT 128 75 108 108 2,545 -24 -61 35 34 -202
Minority Interest
Share Associate 0 0 0 0 0 1 0 -1
Other Related Items
Consolidated Net Profit 169 75 108 109 2,545 -24 -60 34 33 -202
Adjusted EPS 14 8 12 12 362 -3 -9 5 5 -29

Unichem Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 171 87 78 112 68 -112 -328 20 33 -260
Cash Fr. Inv. -118 36 -52 -85 -128 1,648 -286 -36 -74 100
Cash Fr. Finan. -51 -95 -51 -33 59 -881 -2 -62 -121 191
Net Change 1 28 -25 -7 0 655 -616 -78 -162 32
Cash & Cash Eqvt 25 52 27 20 11 666 197 232 77 109

Unichem Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 50.93 50.93 50.93 50.93 50.93 50.93 50.93 50.93 50.93
Public 49.07 49.07 49.07 49.07 49.07 49.07 49.07 49.07 49.07
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Unichem Laboratories Ltd. Announcements

View details >>
Wed, 24 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Financial Results for the quarter and year ended March 31 2023 published in the newspapers on May 24 2023.
Tue, 23 May 2023
Board Meeting Outcome for Approval Of Financial Results For Quarter And Year Ended 31.3.2023
Approval of financial results for quarter and year ended 31.3.2023
Tue, 23 May 2023
Related Party Transactions For Half Year Ended 31St March 2023.
Related Party Transactions For Half Year Ended 31st March 2023.

Unichem Laboratories Ltd. Technical Scans

View details >>
Tue, 06 Jun 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Unichem Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,184.60 1,013.55 +0.4%
Divi's Laboratories Ltd. 93,886.95 3,536.65 +2.2%
Cipla Ltd. 78,522.76 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. 77,195.89 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. 71,115.89 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. 60,794.95 1,796.30 +1.2%
Mankind Pharma Ltd. 59,699.70 1,490.30 +4.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.70 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 51.49 3,536.65 +2.2%
Cipla Ltd. Consolidated 2023-03 28.02 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.13 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.83 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.83 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 44.71 1,490.30 +4.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.34 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.35 3,536.65 +2.2%
Cipla Ltd. Consolidated 2023-03 3.35 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.32 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.49 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.81 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 5.75 1,490.30 +4.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 0.04 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,490.30 +4.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 13.10 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,490.30 +4.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 13.10 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,490.30 +4.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,490.30 +4.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,490.30 +4.6%

Unichem Laboratories Ltd. FAQ's

What is Unichem Lab share price?
Can I buy Unichem Lab shares now?
What is the Dividend Yield of Unichem Lab?
What is the Market Cap of Unichem Lab?
What are the key metrics to analyse Unichem Lab?
What is the 52 Week High and Low of Unichem Lab?
What is the trend of Unichem Lab share price?